A padel version of the Ryder Cup will get underway in 2025 as the rapidly growing sport looks to make the most of its ...

Living with IPF is never dull, says columnist Sam Kirton, who shares some updates on topics he's discussed in recent columns.

The primary focus is on the company’s bexotegrast, an αvß6/αvß1 integrin inhibitor, which is being developed for the treatment of idiopathic pulmonary fibrosis (IPF). The enrollment for the Phase 2b/3 ...

The winner of the Established Business to Business category in The Australian Financial Review Customer Champions list 2024, ...

Panagiotis Tarinidis has unofficially exceeded the U66KG IPF Raw Total World Record with a score of 713 kilograms (1,571.9 ...

A recent study showed that the COPD assessment test was reliable and responsive for assessing health status in fibrotic ...

Pliant Therapeutics (PLRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed ...

IPF severely impacts quality of life, limiting daily activities due to progressive respiratory decline. Median survival for IPF patients is approximately 3 to 5 years post-diagnosis. The financial ...

Columnist Sam Kirton is doing a service for him and his family's future generations by sharing his research on the family ...

IPF diagnosis relies on clinical evaluation, HRCT, and occasionally lung biopsy to identify usual interstitial pneumonia patterns. The average time to IPF diagnosis can be delayed up to two years ...

The Association of Real Estate Funds (AREF), the British Property Federation (BPF) and the Investment Property Forum (IPF) ...